STRIDES PHARMA SCIENCE
Back to Balance Sheet
|
STRIDES PHARMA SCIENCE Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-163 Cr | ₹-150 Cr | ₹-227 Cr | ₹-220 Cr | ₹-179 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of STRIDES PHARMA SCIENCE ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-163 Cr |
| Mar2025 | ₹-150 Cr |
| Mar2024 | ₹-227 Cr |
| Mar2023 | ₹-220 Cr |
| Mar2022 | ₹-179 Cr |
How is Deferred Tax Assets / Liabilities of STRIDES PHARMA SCIENCE Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-163 Cr | Negative | |
| Mar2025 | ₹-150 Cr | Negative | |
| Mar2024 | ₹-227 Cr | Negative | |
| Mar2023 | ₹-220 Cr | Negative | |
| Mar2022 | ₹-179 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of STRIDES PHARMA SCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| STRIDES PHARMA SCIENCE | ₹9,146.7 Cr | 2.5% | -4.7% | 9.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | -1.2% | -2.2% | 15.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹227,958.0 Cr | 1% | 16.3% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,990.0 Cr | 3.2% | -0.8% | 38.6% | Stock Analytics | |
| CIPLA | ₹116,141.0 Cr | -0.9% | 1.6% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,604.4 Cr | -1.7% | -0.1% | -6.5% | Stock Analytics | |
STRIDES PHARMA SCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| STRIDES PHARMA SCIENCE | 2.5% |
-4.7% |
9.9% |
| SENSEX | -0.7% |
0.1% |
-3.4% |
You may also like the below Video Courses